A cross-sectional study of hpv vaccine acceptability in gaborone, botswana

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  DiAngi, Yumi Taylor ^a   Panozzo, Catherine A ^b   Ramogola Masire, Doreen ^a,c   Steenhoff, Andrew P ^a,d   Brewer, Noel T ^b,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b IL   (United States)

^c UNIVERSITY OF BOTSWANA   (Botswana)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;

ADOLESCENT HEALTH; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BOTSWANA; CHILD PARENT RELATION; COMMUNITY CARE; CROSS-SECTIONAL STUDY; DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTAL ATTITUDE; PREVENTIVE HEALTH SERVICE; UTERINE CERVIX CANCER; VACCINATION; ADOLESCENT; CHILD; MIDDLE AGED; MOTHER; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTSWANA; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTHERS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; UTERINE CERVICAL NEOPLASMS;

EID: 80055025625     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025481     Document Type: Article

References (28)

1. World Health Organization (WHO). HPV and related cancers for africa. (2010 November 14).
2. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) 2008 report on the global AIDS epidemic. (2010 November 14).
3. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW, (1994) Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of papanicolaou smears. new york cervical disease study. Obstet Gynecol 84 (4): 591-597.
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, et al. (2007) Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56 (RR-2): 1-24.
5. Brewer NT, Fazekas KI, (2007) Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 45 (2-3): 107-114 10.1016/j.ypmed.2007.05.013.
6. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS, (2010) HPV vaccine acceptability among kenyan women. Vaccine 28 (31): 4864-4867 10.1016/j.vaccine.2010.05.034.
7. Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, et al. (2008) Determinants of human papillomavirus vaccine acceptability in latin america and the caribbean. Vaccine 26 (Suppl 11): L73-9 10.1016/j.vaccine.2008.05.027.
8. Breitkopf CR, Pearson HC, Dinh TA, Tran BC, Vu T, et al. (2009) Human papillomavirus vaccine decision-making in da nang, vietnam: Perceived spousal and adolescent-parent concordance. Vaccine 27 (17): 2367-2371 10.1016/j.vaccine.2009.02.021.
9. Sam IC, Wong LP, Rampal S, Leong YH, Pang CF, et al. (2009) Maternal acceptance of human papillomavirus vaccine in malaysia. J Adolesc Health 44 (6): 610-612 10.1016/j.jadohealth.2008.11.014.
10. Li J, Li LK, Ma JF, Wei LH, Niyazi M, et al. (2009) Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of china. Vaccine 27 (8): 1210-1215 10.1016/j.vaccine.2008.12.020.
11. Madhivanan P, Krupp K, Yashodha MN, Marlow L, Klausner JD, et al. (2009) Attitudes toward HPV vaccination among parents of adolescent girls in mysore, india. Vaccine 27 (38): 5203-5208 10.1016/j.vaccine.2009.06.073.
12. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, et al. (2008) Barriers and facilitators to human papillomavirus vaccination among chinese adolescent girls in hong kong: A qualitative-quantitative study. Sex Transm Infect 84 (3): 227-232 10.1136/sti.2007.029363.
13. Harries J, Moodley J, Barone MA, Mall S, Sinanovic E, (2009) Preparing for HPV vaccination in south africa: Key challenges and opinions. Vaccine 27 (1): 38-44 10.1016/j.vaccine.2008.10.033.
14. Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, et al. (2008) An assessment of the readiness for introduction of the HPV vaccine in uganda. Afr J Reprod Health 12 (3): 159-172.
15. World Health Organization (WHO). HPV and related cancers for botswana. (2010 November 14).
16. United Nations Children's Fund (UNICEF). Botswana statistics. (2010 November 12).
17. McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS, (2009) The carolina HPV immunization attitudes and beliefs scale (CHIAS): Scale development and associations with intentions to vaccinate. Sex Transm Dis.10.1097/OLQ.0b013e3181c37e15.
18. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS, (2009) Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 69 (3): 475-480 10.1016/j.socscimed.2009.05.024.
19. Fazekas KI, Brewer NT, Smith JS, (2008) HPV vaccine acceptability in a rural southern area. J Womens Health (Larchmt) 17 (4): 539-548 10.1089/jwh.2007.0489.
20. Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, et al. (2008) Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health 43 (4 Suppl): S61-7 10.1016/j.jadohealth.2008.06.015.
21. Botswana Export Development and Investment Authority (BEDIA) (2008) Botswana statistics. 2010 November 15.
22. Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL, (2009) Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 27 (11): 1668-1673 10.1016/j.vaccine.2009.01.035.
23. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, et al. (2011) Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 38 (3): 197-204 10.1097/OLQ.0b013e3181f12dbf.
24. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, et al. (2008) Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in manchester: Prospective cohort study. BMJ 336 (7652): 1056-1058 10.1136/bmj.39541.534109.BE.
25. Reeve C, De La Rue S, Pashen D, Culpan M, Cheffins T, (2008) School-based vaccinations delivered by general practice in rural north queensland: An evaluation of a new human papilloma virus vaccination program. Commun Dis Intell 32 (1): 94-98.
26. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N, (2009) Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360 (19): 1981-1988 10.1056/NEJMsa0806477.
27. McFarland DM, (2003) Cervical cancer and pap smear screening in botswana: Knowledge and perceptions. Int Nurs Rev 50 (3): 167-175.
28. Agosti JM, Goldie SJ, (2007) Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med 356 (19): 1908-1910 10.1056/NEJMp078053.